BOSTON, June 1, 2025 – Patients with colon cancer who consumed an anti-inflammatory diet during a phase 3 clinical trial showed longer overall survival post-treatment compared to those on a ...
The results of the phase 3 ATOMIC trial fired another volley in the ongoing debate over adjuvant vs neoadjuvant immunotherapy for patients with locally advanced colon cancer. But experts are divided ...
June 1, 2025 — The Alliance for Clinical Trials in Oncology announced today results from ATOMIC (A021502), a phase III trial evaluating standard chemotherapy alone or combined with atezolizumab ...
The 3-year disease-free survival rate was 86.4% in the atezolizumab arm and 76.6% in the control arm. Adding atezolizumab to adjuvant treatment with mFOLFOX6 (folinic acid, fluorouracil, and ...
Staging means finding out how far colon cancer has spread in your body. Physicians group colon cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback